SU-E-J-254: Evaluating the Role of Mid-Treatment and Post-Treatment FDG-PET/CT in Predicting Progression-Free Survival and Distant Metastasis of Anal Cancer Patients Treated with Chemoradiotherapy

2015 ◽  
Vol 42 (6Part11) ◽  
pp. 3325-3325
Author(s):  
H Zhang ◽  
J Wang ◽  
M Chuong ◽  
W D'souza ◽  
K Latifi ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Anal Cancer ◽  
Distant Metastasis ◽  
Fdg Pet ◽  
Progression Free Survival ◽  
Post Treatment ◽  
Free Survival ◽  
Pet Ct ◽  
Fdg Pet Ct

FDG-PET/CT is Predictive of Progression-free Survival in Anal Cancer

2009 ◽  
Vol 75 (3) ◽  
pp. S258-S259
Author(s):  
W.W. Lien ◽  
A.R. Rao ◽  
J.S. Kaptein ◽  
M.A. Tome
Keyword(s):  
Anal Cancer ◽  
Fdg Pet ◽  
Progression Free Survival ◽  
Free Survival ◽  
Pet Ct ◽  
Fdg Pet Ct

Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET

2020 ◽  
Vol 129 ◽  
pp. 109076
Author(s):  
Dragana P. Sobic Saranovic ◽  
Marina Nikitovic ◽  
Jelena Saponjski ◽  
Isidora Grozdic Milojevic ◽  
Lejla Paripovic ◽  
...  
Keyword(s):  
Ewing Sarcoma ◽  
Fdg Pet ◽  
Young Patients ◽  
Progression Free Survival ◽  
Post Treatment ◽  
Free Survival ◽  
Pet Ct ◽  
Blue Cell ◽  
Fdg Pet Ct

The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients

2019 ◽  
Vol 34 (1) ◽  
pp. 65-73 ◽  
Author(s):  
Lucia Leccisotti ◽  
Stefania Manfrida ◽  
Roberto Barone ◽  
Daria Ripani ◽  
Luca Tagliaferri ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Anal Cancer ◽  
Fdg Pet ◽  
Prognostic Role ◽  
Pet Ct ◽  
Fdg Pet Ct ◽  
Radio Chemotherapy

scholarly journals The role of 18F-FDG PET/CT before and after the treatment of multiple myeloma: Our clinical experience

2017 ◽  
Vol 3 (1) ◽  
pp. 20 ◽  
Author(s):  
Kornelia Kajary ◽  
Zsuzsa Molnár
Keyword(s):  
Multiple Myeloma ◽  
Fdg Pet ◽  
Progression Free Survival ◽  
Focal Lesions ◽  
Free Survival ◽  
Pet Ct ◽  
Before And After ◽  
Fdg Pet Ct

<p>To evaluate the role of FDG PET/CT before and after the treatment of multiple myeloma (MM) in our clinical practice, data from 32 patients (before therapy: 10 patients; after therapy: 22 patients) and from 46 examinations (before therapy: 10; after: 36) with a median time of follow-up of 24 months (before the therapy) and 26 months (after the therapy) were evaluated. FDG PET/CT positivity was characterized by SUVmax &gt;2.5, SUVmax &gt;4.2, focal lesions (FLs) &gt;3, and presence of extramedullary disease (EMD). The median progression-free survival (PFS) and the median overall survival (OS) for FDG PET/CT positive patients were shorter than for negative patients, according to all parameters. Before the therapy, significant correlation was found only between PFS and the number of FLs (<em>p</em> = 0.033). After the treatment, significant correlation was found between PFS and SUVmax (cut-off value 2.5: p &lt; 0.001; cut off value 4.2: p &lt; 0.001), between PFS and the number of FLs (<em>p</em> = 0.009), and between PFS and the presence of EMD (p &lt; 0.001). Significant correlation was found between OS and SUVmax (cut-off value = 2.5, <em>p</em> &lt; 0.001 and 4.2, <em>p</em> = 0.009), between OS and the number of FLs (<em>p</em> = 0.007), and between OS and the presence of EMD (<em>p</em> = 0.022). Our results confirmed the reliability and good prognostic value of FDG PET/CT in MM.</p>

scholarly journals The role of FDG PET/CT in detection of distant metastasis in theinitial staging of breast cancer

2016 ◽  
Vol 46 ◽  
pp. 349-360 ◽  
Author(s):  
Anar ALIYEV ◽  
Sabire YILMAZ AKSOY ◽  
Meftune ÖZHAN ◽  
Özgül EKMEKÇİOĞLU ◽  
Betül VATANKULU ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Distant Metastasis ◽  
Fdg Pet ◽  
Pet Ct ◽  
Fdg Pet Ct
Sign in / Sign up

Export Citation Format

Share Document